The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Targeting IL-33 In Chronic Obstructive Pulmonary Disease (COPD), Chronic Asthma And Idiopathic Pulmonary Fibrosis (IPF)
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
Lung diseases (emphysema, severe asthma & pulmonary fibrosis) are major burdens on Australian community and economy. Airway wounding is a key feature of all these diseases. Patients experience severe breathlessness seriously impacting quality of life and frequently leading to death. We will assess the potential of a new target (IL-33), & therapy (anti-IL-33) in suppressing wounding in experimental models and human tissues. This may lead to a new treatment to reverse and/or prevent lung diseases.
The Role Of Long Non-coding RNA In Regulating Lung Immunity And Inflammation
Funder
National Health and Medical Research Council
Funding Amount
$314,644.00
Summary
Chronic inflammatory diseases of the lung, asthma and COPD, account for significant morbidity and poor quality of life in our community. Respiratory infection is one of the major causes of exacerbation and affects 50-80% of both asthma and COPD patients admitted to hospital. These groups of patients are steroid resistance and difficult to manage. Our aim is to identify novel molecules important in regulating inflammation and to target them therapeutically to treat these patients.
Rehabilitation Exercise At Home (REACH): Improving Equity Of Access And Patient Related Outcomes. A Trial Of Telerehabilitation In Chronic Obstructive Pulmonary Disease (COPD).
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
Chronic obstructive pulmonary disease (COPD) is a chronic lung condition, characterised by breathlessness, and poor exercise tolerance and quality of life. Exercise training (Pulmonary Rehabilitation) improves these problems, however, it is often difficult for people to access these programs, particularly in rural areas, due to lack of availability and issues surrounding transport. These projects aim to determine the benefits and costs of pulmonary rehabilitation delivered via the internet.
An Integrated Approach To Improving Patient-centred Care In Chronic Obstructive Pulmonary Disease
Funder
National Health and Medical Research Council
Funding Amount
$438,768.00
Summary
My research project aims to improve patient-centred care in chronic obstructive pulmonary disease (COPD), also known as emphysema, by developing, testing and implementing a decision aid for shared decision making. The decision aid will be for use during the patient-health provider encounter and will facilitate tailoring of COPD treatment to patient-defined health priorities and needs, thus improving adherence and outcomes.
Characterisation Of A Novel Signaling Network That Translates Early-life Respiratory Infection Into Chronic Lung Disease
Funder
National Health and Medical Research Council
Funding Amount
$316,449.00
Summary
Bacterial and viral respiratory infections in early-life cause permanent damage to the lungs and reduce lung function in later life. They may also increase the risk of developing asthma and emphysema. These are substantial health problems in Australia. My project aims to identify how infections cause these effects. This will enable me to identify new therapeutic targets and develop new therapies for the prevention of chronic lung diseases.